f Upholding Data Integrity in the Pharmaceutical Industry

References

1. DuggineniS.S. Data Integrity as a Code.DIAC2023
   [Google Scholar]
2. AroteK.S. SaladeD.A. PatilN.V. A brief review on regulatory affairs: Ensuring compliance, safety, and market access.Int. J. in Pharm. Sci.,110
   [Google Scholar]
3. SmalleyC.J. Why is there a problem with data integrity?PDA J. Pharm. Sci. Technol201771317010.5731/pdajpst.2017.001101
   [Google Scholar]
4. GiriM.S. GaurB. TomarD. A survey on data integrity techniques in cloud computing.Int. J. Comput. Appl.2015122210.5120/21674‑4762
   [Google Scholar]
5. AgarwalP. MishraA. Pharmaceutical quality audits a review.Int. J. Pharm.2019111142210.22159/ijap.2019v11i1.29709
   [Google Scholar]
6. YuY. AuM.H. AtenieseG. HuangX. SusiloW. DaiY. MinG. Identity-based remote data integrity checking with perfect data privacy preserving for cloud storage.IEEE Trans. Inf. Forensics Security201712476777810.1109/TIFS.2016.2615853
   [Google Scholar]
7. VagadiaB. VagadiaB. Data integrity, control and tokenization.Digital Disruption: Implications and opportunities for Economies, Society, Policy Makers and Business Leaders.Springer202010.1007/978‑3‑030‑54494‑2_5
   [Google Scholar]
8. ReimanA. Kaivo-ojaJ. ParviainenE. TakalaE-P. LauraeusT. Human factors and ergonomics in manufacturing in the industry 4.0 context: A scoping review.Technol. Soc.20216510157210.1016/j.techsoc.2021.101572
   [Google Scholar]
9. KannanS. Auditing as a management tool in pharmaceutical companies.Int. J. Pharm. Biol. Sci.2020101230235
   [Google Scholar]
10. ZikratovI. KuzminA. Niculichev’s V. Ensuring data integrity using blockchain technology20th Conference of Open Innovations Association (FRUCT) Petersburg, Russia, 2017, pp. 534-539, 10.23919/FRUCT.2017.8071359
    [Google Scholar]
11. ZarourM. AleneziM. AnsariM.T.J. PandeyA.K. AhmadM. AgrawalA. KumarR. KhanR.A. Ensuring data integrity of healthcare information in the era of digital health.Healthc. Technol. Lett.202183667710.1049/htl2.1200834035927
    [Google Scholar]
12. AgarwalV. GuptaO.K PriyadarshiniK. AgarwalS. A failure of regulatory diligence and communication: A case study of ranbaxy laboratories Ltd.Available from: https://www.aims-international.org/aims15/15ACD/PDF/A228-Final.pdf
    [Google Scholar]
13. MistryJ. Performance measurement in the pharmaceutical industry: Dr. Reddy’s Laboratories, Ltd.IEEE Eng. Manage. Rev.2018461526410.1109/EMR.2018.2809904
    [Google Scholar]
14. TremblayJ-F. Indian drug firms struggle with quality issues.Chem. Eng. News201694162325
    [Google Scholar]
15. HusnainA. RasoolS. SaeedA. HussainH.K. Revolutionizing pharmaceutical research: harnessing machine learning for a paradigm shift in drug discovery.nt. Multidiscip. Res. J.20232214915710.47709/ijmdsa.v2i2.2897
    [Google Scholar]
16. VoraL.K. GholapA.D. JethaK. ThakurR.R.S. SolankiH.K. ChavdaV.P. Artificial intelligence in pharmaceutical technology and drug delivery design.Pharmaceutics2023157191610.3390/pharmaceutics1507191637514102
    [Google Scholar]
17. shaki AmilrkhanlooM. JahaniD. ChahrdoriM. Artificial intelligence in pharmaceuticals: Exploring applications and legal challenges.Pharm. Biomed. Res202410111010.32598/PBR.10.1.1257.1
    [Google Scholar]